← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Aurora Oncology, Inc.
Golden, CO
$2,749,648
Total funding
3
Grants
Funding over time
peak $1M · FY2012–23$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,749,648 · 3
By mechanism
R44$2,300,637 · 1
R43$449,011 · 2
Investigators at Aurora Oncology, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
DT-EGF Toxic Fusion Protein for the Treatment of Bladder Cancer$1,000,745
R44 · FY2020 · CA
DT-EGF Toxic Fusion Protein for the Treatment of Bladder Cancer$999,955
R44 · FY2023 · CA
Development of Antimicrobial Peptides to Target Gram-negative Pathogens$299,971
R43 · FY2017 · AI
DT-EGF Toxic Fusion Protein for the Treatment of Bladder Cancer$299,937
R44 · FY2018 · CA
DT-EGF Toxic Fusion Protein for Treatment of Bladder Cancer$149,040
R43 · FY2012 · CA